Rgene Corporation
Clinical trials sponsored by Rgene Corporation, explained in plain language.
-
Mushroom extract BLEX 404 joins chemo in fight against lung cancer
Disease control Not yet recruitingThis early-stage study tests whether adding BLEX 404, a liquid extract from maitake mushrooms, to standard chemotherapy (pemetrexed + cisplatin) can safely improve outcomes for people with advanced non-small cell lung cancer that has no EGFR mutation. About 32 participants will r…
Phase: PHASE1, PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New combo therapy targets tough pancreatic cancer
Disease control Not yet recruitingThis study tests a new oral drug, BLEX 404, combined with standard chemotherapy (gemcitabine) in 40 adults with advanced pancreatic cancer that cannot be removed by surgery or has spread. The goal is to find a safe dose and see if the combination shrinks tumors. Participants must…
Phase: PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated May 14, 2026 12:02 UTC